secwatch.observer — SEC 8-K summary
======================================

Issuer:     Relay Therapeutics, Inc. (RLAY)
CIK:        0001812364
Form:       8-K
Filed at:   2026-05-21T21:07:30+00:00
Accession:  0001193125-26-234862
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Relay Therapeutics prices $316M public offering; underwriters exercise overallotment
--------------------------------------------------------------------------------

- Entered underwriting agreement for 22,916,667 shares at $12.00/sh; full exercise of 3,437,500 overallotment option.
- Net proceeds estimated at ~$296.8M after underwriting discounts and expenses; total shares offered 26,354,167.
- Offering expected to close May 22, 2026, led by Jefferies LLC and TD Securities (USA) LLC.
- Shares sold under existing shelf registration statement; significant dilution to existing shareholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1812364/000119312526234862/0001193125-26-234862-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1812364/000119312526234862/d128795d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-234862

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer